Skip to main content
All lobbying filings

S-3 GROUP

Lobbying for NOVO NORDISK, INC. · Pharmaceutical company

 Filing Registration
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 7, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 6
  • MARTIN REISER New on this filing
    Previously held: Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee
  • MICHAELEEN EARLE CROWELL New on this filing
    Previously held: Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders
  • KEVIN CASEY New on this filing
    Previously held: Senior Pol Dir, Dem Caucus; Counselor, Leg. Dir, Leg. Asst, Rep. Joseph Crowley; Staff Asst, Leg. Correspondent, Rep. Bob Weygand
  • MALLOY MCDANIEL New on this filing
    Previously held: Policy Advisor, Senate Minority Leader Mitch McConnell; Whip Liaison, Senate Majority Whip Mitch McConnell; Floor Assistant, Senate Majority Leader Trent Lott; Cloakroom Assistant, Office of the Republican Secretary
  • CHRISTOPHER BUKI New on this filing
    Previously held: Staff Assistant/Legislative Correspondent, Representative John Culberson; Legislative Assistant/Senior Legislative Assistant, Representative Bill Shuster; Legislative Director/Deputy Chief of Staff, Representative David McKinley
  • OLIVIA KURTZ New on this filing
    Previously held: Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 3
Health Issues

Issues related to compounding and counterfeit drugs; drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharamcy benefit management reforms; Most Favored Nation drug pricing; tariffs; importation of counterfeit drugs.

Medicare/Medicaid

Issues related to compounding and counterfeit drugs; drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharamcy benefit management reforms; Most Favored Nation drug pricing; tariffs; importation of counterfeit drugs.

Trade (domestic/foreign)

Issues related to compounding and counterfeit drugs; drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharamcy benefit management reforms; Most Favored Nation drug pricing; tariffs; importation of counterfeit drugs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem